Effect of curcumin and meriva on the lung metastasis of murine mammary gland adenocarcinoma

In Vivo

Volumn 24, Issue 4, 2010, Pages 401-408

  Ibrahim, Abdelazim ^a   El Meligy, Abdelmouneim ^a   Fetaih, Hamdy ^a   Dessouki, Amina ^a   Stoica, George ^b   Barhoumi, Rola ^b  

^a Suez Canal University   (Egypt)

^b TEXAS A AND M UNIVERSITY   (United States)

Author keywords

Curcumin; Mammary gland adenocarcinoma; Meriva; Metastasis; MMP 9

Indexed keywords

ANTINEOPLASTIC AGENT; CURCUMIN; GELATINASE B; MERIVA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST ADENOCARCINOMA; CONTROLLED STUDY; CYTOTOXICITY; DRUG CONJUGATION; DRUG EFFICACY; DRUG MECHANISM; FEMALE; LUNG METASTASIS; MOUSE; NONHUMAN; PROTEIN EXPRESSION;

EID: 77955913176     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Takeda Y, Tsuta K, Shibuki Y, Hoshino T, Tochigi N, Maeshima AM, Asamura H, Sasajima Y, Ito T and Matsuno Y: Analysis of expression patterns of breast cancer-specific markers (mammaglobin and gross cystic disease fluid protein 15) in lung and pleural tumors. Arch Pathol Lab Med 132: 239-243, 2008. (Pubitemid 351213793)
2. Valero V and Hortobagyi GN: Are anthracycline-taxane regimens the new standard of care in the treatment of metastatic breast cancer? J Clin Oncol 21: 959-962, 2003.
3. Kansara M and Thomas DM: Molecular pathogenesis of osteosarcoma. DNA Cell Biol 26: 1-18, 2007.
4. Senior RM, Griffin GL, Fliszar CJ, Shapiro SD, Goldberg GI and Welgus HG: Human 92- and 72-kilodalton type IV collagenases and elastases. J Biol Biochem 266: 7870, 1991.
5. Kunnumakkara AB, Anand P and Aggarwal BB: Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Lett 269: 199-225, 2008.
6. Hatcher H, Planalp R, Cho J, Torti FM and Torti SV: Curcumin: from ancient medicine to current clinical trials. Cell Mol Life Sci 65: 1631-1652, 2008.
7. Woo MS, Jung SH, Kim SY, Hyun JW, Ko KH, Kim WK and Kim HS: Curcumin suppresses phorbol ester-induced matrix metalloproteinase-9 expression by inhibiting the PKC to MAPK signaling pathways in human astroglioma cells. Biochem Biophys Res Commun 335: 1017-1025, 2005.
8. Aggarwal BB, Shishodia S, Takada Y, Banerjee S, Newman RA, Bueso-Ramos CE and Price JE: Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice. Clin Cancer Res 11: 7490-7498, 2005
9. Bachmeier B, Nerlich AG, Iancu CM, Cilli M, Schleicher E, Vené R, Dell'Eva R, Jochum M, Albini A and Pfeffer U: The chemopreventive polyphenol Curcumin prevents hematogenous breast cancer metastases in immunodeficient mice. Cell Physiol Biochem 19: 137-152, 2007. (Pubitemid 46270897)
10. Wang L, Shen Y, Song R, Sun Y, Xu J and Xu Q: An anticancer effect of curcumin mediated by down-regulating PRL-3 expression on highly metastatic melanoma cells. Mol Pharmacol 76(6): 1238-1245, 2009.
11. Kunnumakkara AB, Guha S, Krishnan S, Diagaradjane P, Gelovani J and Aggarwal BB: Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaB-regulated gene products. Cancer Res 67: 3853-3861, 2007. (Pubitemid 46762173)
12. Somers-Edgar TJ, Scandlyn MJ, Stuart EC, Le Nedelec MJ, Valentine SP and Rosengren RJ: The combination of epigallocatechin gallate and curcumin suppresses ER alpha-breast cancer cell growth in vitro and in vivo. Int J Cancer 122: 1966-1971, 2008.
13. Cheng AL, Hsu CH, Lin JK, Hsu MM, Ho YF, Shen TS, Ko JY, Lin JT, Lin BR, Ming-Shiang W, Yu HS, Jee SH, Chen GS, Chen TM, Chen CA, Lai MK, Pu YS, Pan MH, Wang YJ, Tsai CC and Hsieh CY: Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res 21: 2895-2900, 2001.
14. Sharma RA, Gescher AJ and Steward WP: Curcumin: the story so far. Eur J Cancer 41: 1955-1968, 2005.
15. Marczylo TH, Verschoyle RD, Cooke DN, Morazzoni P, Steward WP and Gescher AJ: Comparison of systemic availability of curcumin with that of curcumin formulated with phosphatidylcholine. Cancer Chemother Pharmacol 60: 171-177, 2007.
16. Hall DG and Stoica G: Characterization of brain and bone-metastasizing clones selected from an ethylnitrosourea-induced rat mammary carcinoma. Clin Exp Metastasis 12: 283-295, 1994.
17. Hall DG and Stoica G: Effect of the bisphosphonate risedronate on bone metastases in a rat mammary adenocarcinoma model system. J Bone Miner Res 9: 221-230, 1994.
18. Mendes O, Kim HT, Lungu G and Stoica G: MMP2 role in breast cancer brain metastasis development and its regulation by TIMP2 and ERK1/2. Clin Exp Metastasis 24: 341-351, 2007. (Pubitemid 47124935)
19. Sugiura Y, Shimada H, Seeger RC, Laug WE and DeClerck YA: Matrix metalloproteinase-2 and -9 are expressed in human neuroblastoma: contribution of stromal cells to their production and correlation with metastasis. Cancer Res 58: 2209, 1998.
20. Ellis LM, Takahashi Y, Liu W and Shaheen RM: Vascular endothelial growth factor in human colon cancer: biology and therapeutic implications. Oncologist 5: 11-15, 2000.
21. Ravindran J, Prasad S and Aggarwal BB: Curcumin and cancer cells: how many ways can curry kill tumor cells selectively? AAPS J 11 : 495-510, 2009.
22. Ramachandran C and You W: Differential sensitivity of human mammary epithelial and breast carcinoma cell lines to curcumin. Breast Cancer Res Treat 54: 269-278, 1999. (Pubitemid 29322350)
23. 2 phase of cell cycle in a p53-dependent manner. J Biol Chem 280: 20059-20068, 2005.
24. Moussavi M, Assi K, Gomez-Munoz A and Salh B: Curcumin mediates ceramide generation via the de novo pathway in colon cancer cells. Carcinogenesis 27: 1636-1644, 2006.
25. 2+ and the activation of caspase-3. Anticancer Res 26: 4379-4389, 2006.
26. Khor TO, Keum YS, Lin W, Kim JH, Hu R, Shen G, Xu C, Gopalakrishnan A, Reddy B, Zheng X, Conney AH and Kong AN: Combined inhibitory effects of curcumin and phenethyl isothiocyanate on the growth of human PC-3 prostate xenografts in immunodeficient mice. Cancer Res 66: 613-621, 2006.
27. Chaudhary LR and Hruska KA: Inhibition of cell survival signal protein kinase B/Akt by curcumin in human prostate cancer cells. J Cell Biochem 89: 1-5, 2003. (Pubitemid 36459092)
28. Bharti AC, Donato N, Singh S and Aggarwal BB: Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-kappa B and IkappaBalpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis. Blood 101: 1053-1062, 2003.
29. Aoki H, Takada Y, Kondo S, Sawaya R, Aggarwal BB and Kondo Y: Evidence that curcumin suppresses the growth of malignant gliomas In vitro and in vivo through induction of autophagy: Role of Akt and ERK signaling pathways. Mol Pharmacol 72: 29-39, 2007.
30. Lin LI, Ke YF, Ko YC and Lin JK: Curcumin inhibits SK-Hep-1 hepatocellular carcinoma cell invasion in vitro and suppresses matrix metalloproteinase-9 secretion. Oncology 55: 349-353, 1998.
31. Lin SS, Lai KC, Hsu SC, Yang JS, Kuo CL, Lin JP, Ma YS, Wu CC and Chung JG: Curcumin inhibits the migration and invasion of human A549 lung cancer cells through the inhibition of matrix metalloproteinase-2 and -9 and vascular endothelial growth factor (VEGF). Cancer Lett 285(2): 127-133, 2009.
32. Hong JH, Ahn KS, Bae E, Jeon SS and Choi HY: The effects of curcumin on the invasiveness of prostate cancer in vitro and in vivo. Prostate Cancer Prostatic Dis 9: 147-52, 2006.
33. Li M, Zhang Z, Hill DL, Wang H and Zhang R: Curcumin, a dietary component, has anticancer, chemosensitization, and radiosensitization effects by down-regulating the MDM2 oncogene through the PI3K/mTOR/ETS2 pathway. Cancer Res 67: 1988-1996, 2007.
34. Ohashi Y, Tsuchiya Y, Koizumi K, Sakurai H and Saiki I: Prevention of intrahepatic metastasis by curcumin in an orthotopic implantation model. Oncology 65: 250-258, 2003. (Pubitemid 37505833)
35. Lin YG, Kunnumakkara AB, Nair A, Merritt WM, Han LY, Armaiz-Pena GN, Kamat AA, Spannuth WA, Gershenson DM, Lutgendorf SK, Aggarwal BB and Sood AK: Curcumin inhibits tumor growth and angiogenesis in ovarian carcinoma by targeting the nuclear factor-kappaB pathway. Clin Cancer Res 13: 3423-3430, 2007.
36. Anand P, Kunnumakkara AB, Newman RA and Aggarwal BB: Bioavailability of curcumin: problems and promises. Mol Pharm 4: 807-818, 2007.
37. Burgos-Moron E, Calderón-Montaño JM, Salvador J, Robles A and López-Lázaro M: The dark side of curcumin. Int J Cancer 126(7): 1771-1775, 2010.
38. Anand P, Thomas SG, Kunnumakkara AB, Sundaram C, Harikumar KB, Sung B, Tharakan ST, Misra K, Priyadarsini IK, Rajasekharan KN and Aggarwal BB: Biological activities of curcumin and its analogs (congeners) made by man and Mother Nature. Biochem Pharmacol 76: 1590-1611, 2008.
39. Maiti K, Mukherjee K, Gantait A, Saha BP and Mukherjee PK: Curcumin-phospholipid complex: Preparation, therapeutic evaluation and pharmacokinetic study in rats. Int J Pharm 330: 155-163, 2007
40. Cucuzza LS, Motta M, Miretti S and Accornero Pand Baratta M: Curcuminoid-phospholipid complex induces apoptosis in mammary epithelial cells by STAT-3 signaling. Exp Mol Med 40: 647-657, 2008.
41. Pereira MA, Grubbs CJ, Barnes LH, Li H, Olson GR, Eto I, Juliana M, Whitaker LM, Kelloff GJ, Steele VE and Lubet RA: Effects of the phytochemicals, curcumin and quercetin, upon azoxymethane-induced colon cancer and 7,12-dimethylbenz[a]anthracene-induced mammary cancer in rats. Carcinogenesis 17: 1305-1311, 1996.
42. Wicha MS, Liu S and Dontu G: Cancer stem cells: an old idea-a paradigm shift. Cancer Res 66: 1883-1890, 2006
43. Scorilas A, Karameris A, Arnogiannaki N, Ardavanis A, Bassilopoulos P, Trangas T and Talieri M: Overexpression of matrix-metalloproteinase-9 in human breast cancer: a potential favorable indicator in node-negative patients. Br J Cancer 84: 1488-1496, 2001. (Pubitemid 32579341)
44. Lee SO, Jeong YJ, Kim M, Kim CH and Lee IS: Suppression of PMA-induced tumor cell invasion by capillarisin via the inhibition of NF-kappaB-dependent MMP-9 expression. Biochem Biophys Res Commun 366: 1019-1024, 2008.
45. Mendes O, Kim HT and Stoica G: Expression of MMP2, MMP9 and MMP3 in breast cancer brain metastasis in a rat model. Clin Exp Metastasis 22: 237-246, 2005.